Please login to the form below

Not currently logged in
Email:
Password:

Amgen finance VP joins True North Therapeutics

Pamela Wapnick appointed as chief financial officer

California-based True North Therapeutics has appointed Pamela Wapnick as its new chief financial officer.

Wapnick joins the rare diseases clinical stage biopharmaceutical company from Amgen, where she most recently served as vice president of finance.

Prior to this, Wapnick had corporate finance responsibility for Amgen's global research and development activities, and has served as vice president and treasurer of Amgen.

She brings over 25 years of international business and finance experience to True North, including senior financial management positions at Delphi Corporation, Federal Mogul Corporation and General Motors Corporation.

Nancy Stagliano, chief executive officer of True North, said: “I am pleased to announce Pam's appointment to the position of chief financial officer as a member of our management team.

“Her breadth of experience in corporate finance and treasury within the biotechnology industry, including nearly 10 years and Amgen, will serve us well as we continue to advance True North's pipeline of novel product candidates.”

3rd August 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics